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Abstract Between 1982 and 2006, there were 89 distinct
publications dealing with oral appliance therapy involving a
total of 3,027 patients, which reported results of sleep studies
performed with and without the appliance. These studies,
which constitute a very heterogeneous group in terms of
methodology and patient population, are reviewed and the
results summarized. This review focused on the following
outcomes: sleep apnea (i.e. reduction in the apnea/hypopnea
index or respiratory disturbance index), ability of oral
appliances to reduce snoring, effect of oral appliances on
daytime function, comparison of oral appliances with other
treatments (continuous positive airway pressure and sur-
gery), side effects, dental changes (overbite and overjet), and
long-term compliance. We found that the success rate,
defined as the ability of the oral appliances to reduce
apnea/hypopnea index to less than 10, is 54%. The response
rate, defined as at least 50% reduction in the initial apnea/
hypopnea index (although it still remained above 10), is
21%. When only the results of randomized, crossover,
placebo-controlled studies are considered, the success and
response rates are 50% and 14%, respectively. Snoring was
reduced by 45%. In the studies comparing oral appliances to
continuous positive airway pressure (CPAP) or to uvulopa-
latopharyngoplasty (UPPP), an appliance reduced initial
AHI by 42%, CPAP reduced it by 75%, and UPPP by 30%.
The majority of patients prefer using oral appliance than
CPAP. Use of oral appliances improves daytime function
somewhat; the Epworth sleepiness score (ESS) dropped
from 11.2 to 7.8 in 854 patients. A summary of the follow-up
compliance data shows that at 30 months, 56–68% of
patients continue to use oral appliance. Side effects are
relatively minor but frequent. The most common ones are
excessive salivation and teeth discomfort. Efficacy and side
effects depend on the type of appliance, degree of protrusion,
vertical opening, and other settings. We conclude that oral
appliances, although not as effective as CPAP in reducing
sleep apnea, snoring, and improving daytime function, have




Treatment of sleep-disordered breathing (i.e. snoring, upper
airway resistance syndrome, sleep apnea syndrome) can be
divided into four general categories. These include: (1)
lifestyle modification, i.e. weight loss, cessation of evening
alcohol ingestion, sleep position training, (2) upper airway
surgery, (3) oral appliances, and (4) CPAP. Although the
latter category provides the most reliable therapeutic modal-
ity and is the most widely used method to treat sleep-
disordered breathing today—it is also the most cumbersome
one. Many patients, particularly young non-apneic snorers,
find it unappealing, difficult to tolerate, and unacceptable.
The only other non-invasive alternative, which can produce
favorable results within a short time, is oral appliances.
Although there are several reviews of oral appliances,
which have appeared since the start of the new millennium
[1–6], including a recent review and practice parameters for
treatment of snoring and sleep apnea [124, 125], this
treatment modality is still underutilized. Even the dentists
who are primary providers of this treatment, lack education
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dentists in the state of Indiana and found that 40% “knew
little or nothing about oral appliances for treatment of
obstructive sleep apnea”. Unarguably, the knowledge about
oral appliances among dentists and physicians varies
geographically, being higher in large urban centers, which
provide more educational opportunities locally, but the
results of the survey certainly indicate a need for more
education in this area.
This review will summarize our current state of
knowledge of the efficacy of oral appliances for the
treatment of snoring and obstructive sleep apnea. We shall
not limit this review to a simple summary of the effect of
oral appliances on nocturnal respiration, but will also
examine other aspects of this therapy, such as the reduction
in symptoms, vascular consequences, side effects, and
compliance. However, the main objective of this review
will remain to be the examination of the current data
dealing with the efficacy of oral appliance therapy for the
treatment of snoring and sleep apnea.
Historical aspects
George Cattlin [8] was probably the first person who seriously
thought that the route of breathing may influence sleep quality
and daytime function. He attributed good health of the native
North American Indians, compared to their immigrant
European counterparts, to the fact that they are taught, from
the early age, to breathe through the nose rather than the
mouth. He pointed out that breathing through the nose
promotes more restful and better quality sleep, which trans-
lates into better daytime function and better general health.
After the publication of his book, there appeared many patents
describing devices designed to promote nasal breathing. Some
of the early patented appliances are shown in Fig. 1.
However, modern published clinical work begins in
1903, when Pierre Robin first described a device, called the
“monoblock”, for the treatment of glossoptosis [9]. More
than 30 years later, he used an oral appliance to reposition
the mandible [10]. For the next 50 years, little work was
done in this field. It took almost another 50 years to start
using oral appliances for the treatment of snoring and sleep
apnea when Cartwright and Samelson [11] described the
tongue retaining device in 1982. This work stimulated
further investigations, resulting in many subsequent studies,
many of which will be summarized in this review.
Types of appliances
Although the type and number of specific appliances may
be bewildering and is still growing (Table 1), all may be
divided into three general groups: soft palate lifters (SPL),
tongue retaining devices (TRD), and mandibular advance-
ment appliances (MAA). The first category is virtually no
longer in use today. The second category is used very
seldom, mainly if there are dental reasons precluding the
construction of MAA. The last category (MAA) is by far
the most common type of dental appliance in use today. It
protrudes the mandible forward, thus preventing or mini-
mizing upper airway collapse during sleep. These devices
can be either fixed (i.e. the protrusion distance cannot be
changed), or variable (i.e. protrusion can be increased or
decreased). The final protrusion distance represents a
delicate balance between side effects and efficacy. For this
reason, the construction and fitting of the appliance should
be done by a dentist with an expertise in this area who is
familiar with different appliances, is capable of selecting
the appropriate one based on the dental examination and
has access to a sleep laboratory where the objective efficacy
of the appliance can be verified.
Mechanism of action of oral appliances
Much was written on how and why oral appliances may
improve snoring and sleep apnea. The results show that
upper airway obstruction during sleep may occur at any site
between the nasopharynx and the larynx. The most
common sites of obstruction are behind the base of the
tongue (retroglossal) and behind the soft palate (retropala-
tal). This partial or complete occlusion of the upper airway
during sleep is a consequence of abnormal anatomy and
physiology (i.e. the airway is narrow and “floppy”). There
is still a lively debate as to the relative contributions of
abnormal anatomy vs abnormal physiology in the patho-
genesis of upper airway obstruction during sleep [12, 13].
This debate is partially fuelled by the fact that airway
narrowing or even a complete occlusion is a normal
physiological event during sleep. In patients with sleep
apnea, this normal response is exaggerated. The question
then becomes whether this exaggerated response is due to
abnormal neuromuscular control superimposed on the
otherwise anatomically normal airway, or is the airway
anatomically narrower than normal without any abnormal-
ities in the neuromuscular control. It is now an accepted
fact that a combination of abnormal anatomy and
physiology is necessary to produce pathological repetitive
narrowing (or complete occlusion) of upper airway during
sleep—i.e. sleep apnea.
Given that sleep apnea and snoring are a consequence of
abnormal anatomy and physiology of the upper airway, is
there evidence that oral appliances can correct these
abnormalities, at least in some patients? There are several
studies, not only during wakefulness, but also during sleep,
2 Sleep Breath (2007) 11:1–22indicating that advancing the mandible forward can enlarge
the airway and reduce pharyngeal collapsibility [14–19,
120, 123] in normal subjects and patients with sleep apnea.
These investigations confirmed the effect of oral appliances
on upper airway properties. Some authors suggested that
measurements of airway pressures during sleep may even
predict the beneficial response to oral appliances. For
example, recently, Battagel et al. [19] performed sleep
nasendoscopy in 27 patients with sleep apnea. The
mandible was gently advanced by 4–5 mm to simulate
the effect of the mandibular appliance. The authors
suggested that this procedure may help to determine
whether a particular patient is a candidate for oral appliance
therapy. Similarly, Ng et al. [123] measured upper airway
pressures during natural sleep in 12 patients with obstruc-
tive sleep apnea to identify the site of airway collapse. The
authors found that oropharyngeal, rather than velopharyn-
geal collapse, was predictive of the beneficial response to
oral appliance. However, another study of 25 patients with
sleep apnea where esophageal pressure was measured
during sleep, found no significant differences in nadir
esophageal pressure or cephalometric parameters between
Table 1 Examples of oral appliances
Oral appliances
The Equilizer Jasper jumper Esmark
The Silencer PM Positioner TPE
Klearway Tongue locking appliance SnoreEx
NAPA Adjustable soft palate lifter HAP
TAP Z-training appliance Tessi
TOPS Snore-no-more Snore Guard
SNOAR Elastometric Silent Night
Herbst SUAD TheraSnore
Fig. 1 Examples of early oral
appliances
Sleep Breath (2007) 11:1–22 3the patients who responded to oral appliance therapy and
those who did not [120].
It is safe to conclude at this time that anatomical changes
in the oropharynx, produced by mandibular advancement,
result in the alterations of the intricate relationships
between different muscle groups controlling the upper
airway caliber. In some patients with sleep apnea these
alterations may prevent the obstruction, in others—worsen
the obstruction, and yet in others, particularly in those with
low level obstruction, the part of the airway where the
obstruction occurs may be unaffected. There is currently no
reliable way to predict the outcome of treatment with oral
appliance in individual patients and therefore to select
appropriate candidates for this treatment. Clinical features
also do not seem to offer much help in trying to predict who
will respond to oral appliances, or just the opposite, to
identify patients who are not likely to respond to this
therapy. When two expert maxillofacial surgeons examined
(in a blind fashion) 100 patients with sleep apnea to
determine if there were any contraindications to mandibular
advancement devices, they found that primary contra-
indications were present in 34% of patients [20]. This
relatively high rate of contraindications and disagreements
between individual experts only point out that a team
approach is necessary to select the proper treatment for
patients with sleep apnea.
Results of clinical trials
The onset of the new millennium carried forward the
momentum started by Cartwright and Samelson [11]
resulting in the increased use of oral appliances for the
treatment of snoring and sleep apnea. However, the
emphasis on the type of appliances has changed. Tongue
retaining devices are currently seldom used, being almost
completely replaced by the mandibular advancement
appliances. The latter are sometimes also called mandibular
repositioners, protruders, devices, splints, prosthesis, etc.—
but the common feature of all these appliances is their
ability to adjust the degree of mandibular advancement to
achieve resolution of snoring and sleep apnea.
In what follows, we shall summarize the results of
clinical trials employing oral appliances for the treatment of
sleep apnea and snoring. In addition, we shall review and
summarize the information regarding changes in daytime
function as a result of using the appliance, clinical and
dental side effects, and compliance with treatment.
Oral appliances for the treatment of sleep apnea
Table 2 summarizes the results of individual studies using
oral appliances starting with the 1982 polysomnographic
study of TRD by Cartwright and Samelson [11] until the
present. The only criterion for the inclusion of a particular
study into this table, and thus the only common feature of
all studies listed, was the availability of at least partial
results of nocturnal monitoring of respiration with and
without oral appliance. Otherwise, the studies are highly
variable in their design, methodology, data analysis,
outcome definition and assessment and presentation of
results. This makes the interpretation of individual results,
and particularly any attempt to summarize all of them, very
challenging. Before describing the methods of analysis and
presenting the summary of the data, it is very important to
keep in mind the following points.
First, Table 2 contains the studies from the two extreme
ends of the spectrum of scientific rigor. At the highest end
of the spectrum there are prospective, randomized, cross-
over, controlled (either against placebo-appliance or another
treatment modality) studies. At the lowest end of the
spectrum are individual case reports. Some studies are
prospective case series, but most studies are retrospective
analysis of series of cases.
Second, the investigations listed in Table 2 form a very
inhomogeneous group with respect to several variables:
time of follow-up study, type of polysomnography, which
respiratory variables measured, presentation of results, type
of oral appliance used, missing data, etc. The time interval
between the diagnostic and “with appliance” polysomnog-
raphy varied from a few hours to a few months. In some
studies, split polysomnography (i.e. diagnostic part fol-
lowed by “with appliance” part) was carried out, while in
others, the two sleep studies were separated by a couple of
days to several months. In some investigations, formal in-
hospital polysomnography was performed, while in others,
only at-home monitoring of oxygen saturation was carried
out. In some of the earliest investigations, only the apnea
index (AI) was measured. Later investigations reported the
oxygen desaturation index (number of times per hour of
sleep that oxygen saturation falls by more the 4% from the
baseline—ODI4). Recent investigations all reported either
the apnea–hypopnea index (AHI) or the respiratory distur-
bance index (RDI). Most investigations presented only the
mean values, rather than the individual data, and some
presented only the median values. Oral appliances used by
the investigators included tongue retaining devices, soft
palate lifters, and fixed and variable mandibular advance-
ment appliances. In the vast majority of investigations, the
mandibular advancement appliance was used, less than ten
investigations employed the TRD, and only one investiga-
tion used the soft palate lifter. In many investigations, not
all patients who had a diagnostic sleep study also had a
follow-up “with appliance” study.
Clearly, the above factors have a significant effect on the
analysis of the pooled data presented in Table 2.
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[11] 14 TRD 56 27 14 14 Case series; AI
[22] 16 TRD 54 33 19 32 Case series; AI
[23] 16 TRD ––– 56 Case series; all patients had SMR or UPPP; AI
[24] 1 TRD 79 5 100 – Case report; AI
[25] 7 MAA 37 12 57 43 Case series; Esmarch prosthesis; AI
[26] 44 MAA 50 23 – 59 Case series; Esmarch prosthesis; AI
[27] 5 TRD 48 9 40 60 Case series; NAPA; AI
[28] 12 MAA 54 36 25 17 Case series; modified functional appliance
[29] 1 MAA 35 9 100 – Case report; mandibular repositioning appliance
[30] 12 TRD 37 17 58 17 Case series
[31] 1 MAA 57 2 100 – Case report; mandibular repositioning appliance
[32] 15 TRD 27 11 73 0 Case series
[33] 14 MAA 32 9 43 57 Case series; fixed splint; AI
[34] 20 MAA 47 20 35 40 Case series; fixed dental orthosis
[35] 12 MAA 50 19 –– Case series; fixed prosthesis; AI
[36] 2 MAA 30 7 50 50 Two case reports; intra-oral fixed prosthesis; RDI
[37] 16 MAA 37 9 69 25 Case series; NAPA; RDI
[38] 24 MAA 48 12 73 13 Prospective case series; Herbst-like; RDI
[39] 19 MAA 35 13 –– Case series of CPAP failures; Herbst
[40] 20 MAA 57 26 20 40 Case series; Esmarch; AI
[41] 12 MAA 45 30 –– Case series; Herbst vs MR (muscle relaxation) appliance; result
for Herbst; ODI4
[41] 12 MAA 45 41 –– Case series; Herbst vs MR (muscle relaxation) appliance; result
for MR; ODI4
[42] 51 MAA 32 18 –– Case series; mandibular advancement splint fixed 75% of
maximum protrusion
[43] 4 MAA 200 110 – 75 Case series; fixed intra-oral prosthesis; apneas/night
[44] 30 MAA 65 31 –– Case series; Esmarch; AI
[45] 21 MAA 34 20 19 24 Crossover, comparing AMP device with CPAP
[46] 19 MAA 20 10 68 11 Randomized, prospective crossover comparing the Snore-Guard
with CPAP
[47] 23 MAA 37 18 52 30 Case series; mandibular repositioning device;most patients were
CPAP failures; RDI
[48] 1 MAA 34 3 100 – Case report; elastometric sleep appliance
[49] 14 TRD 38 30 0 0 Case series: SnorEx appliance; RDI
[50] 20 MAA 25 14 55 21 Randomized, crossover comparing the AMP device with CPAP
[51] 8 MAA 44 12 63 13 Case series; mandibular advancing positioner
[52] 1 MAA 53 4 100 – Case report; fixed dental appliance
[53] 14 MAA 4 4 –– Fixed mandibular splint; maximum protrusion; median AHI
[53] 9 MAA 7 1 –– Fixed mandibular splint; 70% of maximum protrusion; median
AHI
[54] 44 MAA 25 9 64 16 Case series, prospective; mandibular advancement device
[55] 18 MAA 42 15 61 11 Case series of UPPP failures; Herbst
[56] 25 MAA 33 9 72 12 Case series;mandibular positioning device; RDI
[57] 15 MAA 193 20 –– Case series of snorers; mandibular advancement device; snores/
h of sleep
[58] 14 MAA 36 5 71 21 Case series; Serenox
[59] 41 MAA 18 12 78 3 Prospective, randomized, parallel groups comparing dental
appliance with UPPP
[60] 75 MAA 44 12 51 28 Case series; TAP appliance
[61] 11 MAA 45 10 –– Case series; dental appliance
[62] 15 MAA 28 8 –– Case series; Klearway appliance
[63] 28 MAA 53 21 32 36 Case series; elastic mandibular advancement device
[64] 37 MAA 26 11 50 15 Case series; three fixed appliances with 2, 4 and 6 mm protrusion;
ODI4





[65] 8 MAA 72 36 13 50 Case series comparing MAA (Snore-Guard) with TRD and with
soft palate lifter (SPL)
[65] 5 TRD 50 44 –– Ibid
[65] 2 SPL 47 57 –– Ibid
[66] 10 MAA 41 12 60 30 Case series; Herbst
[67] 38 MAA 33 12 55 18 Case series; Klearway
[68] 24 MAA 23 9 67 – Randomized, crossover comparing Herbst vs monoblock; results
given for Herbst
[69] 39 MAA 17 8 59 – Case series; SnorBan
[70] 256 MAA 43 18 54 14 Case series; mandibular advancement device
[71] 22 MAA 40 12 59 23 Case series; modified functional appliance
[72] 24 MAA 30 14 38 25 Randomized, placebo-appliance-controlled, crossover; mandibular
advancement splint
[73] 22 MAA 28 6 –– Case series; either Herbst or monoblock
[74] 72 MAA 43 22 53 22 Case series; adjustable mandibular splints
[75] 25 MAA 3.4 1.8 –– Randomized, placebo-appliance-controlled, crossover series of
snorers; snoring measured on a 0–4 scale
[76] 33 MAA 25 9 58 – Prospective case series; mandibular advancement device
[77] 23 MAA 21 8 52 22 Randomized, crossover, comparing 4 mm with 14 mm
inter-incisal opening; results for 4 mm opening
[78] 7 MAA 67 20 43 43 Case series; Herbst-like
[79] 32 MAA 18 7 63 9 Randomized, parallel groups comparing UPPP and MAA
[80] 26 MAA 18 8 88 12 Case series; Karwetzky activator
[81] 34 MAA 22 7 –– Case series; Karwetzky activator; median AHIs
[82] 73 MAA 27 12 36 27 Randomized, crossover, placebo-appliance-controlled
[83] 6 MAA 13 6 83 0 Case series; titration study; results for maximum protrusion;
Klearway
[84] 20 MAA 18 14 30 – Randomized, crossover, comparing CPAP with ISAD appliance
[85] 48 MAA 31 15 47 – Randomized, crossover, comparing CPAP with mandibular
repositioning splint
[86] 20 MAA 38 23 33 – Randomized, crossover, placebo-appliance-controlled; mandibular
advancement splint
[87] 34 MAA 29 4 –– Case series comparing patients on CPAP who switched to MAA
[88] 24 MAA 22 8 70 – Prospective randomized crossover, comparing MAS with CPAP;
soft one-piece mandibular advancement splint
[89] 40 MAA 50 16 52 28 Prospective, randomized, parallel groups comparing 75% and
50% of mandibular protrusion; results for 75% group
[90] 26 MAA 19 6 73 4 Prospective, randomized, parallel groups comparing 75% and
50% of mandibular protrusion; results for 75% group
[91] 25 MAA 38 15 44 24 Case series; The Silencer appliance
[92] 80 MAA 21 14 –– Randomized, crossover, controlled, comparing mandibular
advancement splint with CPAP and with placebo tablet
[93] 44 MAA 46 12 64 18 Case series; titration protocol; Herbst-like
[94] 19 MAA 34 17 37 11 Case series; titration protocol; Klearway
[95] 277 MAA 21 8 54 – Case series; mandibular advancement devices
[96] 11 MAA 3 2 –– Prospective case series of non-apneic snorers; Herbst; ODI4
[97] 20 MAA 8 4 –– Case series; fixed mandibular advancement device
[98] 34 MAA 20 3 94 0 Case series of consecutive patients; TAP appliance
[99] 17 MAA 25 15 –– Case series of patients with CHF; mandibular advancement device
[19] 19 MAA 32 8 79 11 Case series; Herbst
[100] 16 MAA 46 24 –– Prospective, randomized, crossover comparing Twin Block and
Herbst; median AHI
[101] 251 MAA 29 16 –– Mail survey of 544 patients; RDI; mainly Klearway, few
mandibular repositioners, fewer TRDs
[114] 21 MAA 34 25 5 38 Case series; Klearway appliance
[115] 92 MAA 18 –– – Case series; questionnaires; bed partners’ replies recorded
Table 2 (continued)
rate (%) rate (%)
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investigations is to decide on which outcome variables to
analyze. Since we are interested in sleep apnea, the
following four variables are an obvious choice—baseline
index of respiration (we shall denote this as AHIbase), “with
appliance” index of respiration (denoted as AHIappl),
success rate defined as the reduction of AHIbase to a value
less than the defining value for sleep apnea, and response
rate defined as the reduction of AHIbase by greater than
50% while still remaining higher than the defining value for
sleep apnea.
Table 2 lists 89 distinct investigations, involving a total
of 3,027 patients. Inspection of the individual results
indicates the widest possible variability. Respiration is
analyzed in terms of AI, ODI4, AHI, or RDI. The definition
of sleep apnea was based either on AI<5, AHI<10, RDI<
10 or ODI4<10. Success and response rates were defined
differently in many studies; however, whenever possible we
extracted the information to calculate the success and
response rates according to the standard definition given
above. In other words, no matter what definition of sleep
apnea was employed in a particular study, i.e. whether it
was defined as AI<5, AHI<10, or ODI<10, etc.—the
success rate we calculated was based on the percent of
patients in whom AHIappl w a sl e s st h a n1 0 ,a n dt h e
response rate was calculated as the percent of patients in
whom 10<AHIappl<0.5×AHIbase.
Clearly, it is not possible to carry out a meta-analysis of
these studies because of the differences in study design, data
collection, statistical analysis and presentation of the data.
Even the simple descriptive statistics based on the pooled
data must be interpreted with caution due to the methodo-
logical differences listed above. To obtain the general
information about the efficacy of oral appliances, we
analyzed the results of individual investigations in several
different ways, as follows.
First, we rejected all case reports [24, 29, 31, 48, 52] and
all studies, which did not report the mean AI, the mean
AHI, or the mean RDI [43, 53, 57, 64, 75, 81, 96, 100,
120]. These studies reported either the total number of
apneas per night, snoring only, median AHI, or ODI4, etc.
This procedure left a total of 75 studies involving 2,832
patients. We used this “pooled” data to calculate the
“pooled” means for each outcome variable—AHIbase,
AHIappl, success rate and response rate. If an individual
study did not report this outcome variable—it was not used
in the calculation of pooled means. For example, to
calculate the AHIbase, we only had to reject 1 study [23]
where this variable was not reported, thus leaving 74
studies with 2,816 patients. To calculate the AHIappl,w e
had to reject 2 studies [23, 115], thus leaving 73 studies
with a total of 2,724 patients. Similarly, looking at Table 2,
we can easily see which studies had to be rejected to
calculate the success and the response rates. The results are
shown in Table 3. We note that oral appliance reduced the
AHIbase from 31 to 14. The success and response rates were
54% and 21%, respectively.
A second way to analyze the data presented in Table 2 is
to select only those investigations where all four outcome
variables (AHIbase, AHIappl, success rate, response rate)
were reported. This left 49 studies involving 1,517 patients.
It is interesting to note that the results shown in Table 4, are
almost identical to what was found in a larger dataset.
A third way to analyze the data is to select only the
randomized, crossover, placebo-controlled studies. There
are only five such studies—all done after the year 2000 and
all using the mandibular advancement appliance. Inactive
appliance was used as placebo in four studies [72, 82, 86,
122], and a pill was used as placebo in one study [92]. In
the latter study, only the mean AHIs were reported, but not





[120] 25 MAA 35.9 8.2 60 – Median AHI; case series; 6 weeks use; split polysomnography
[121] 4 MAA 49.5 11.7 75 25 Case series
[122] 73 MAA 24.4 12.2 55 – Prospective, randomized, placebo-appliance-controlled 4 weeks
study
[123] 12 MAA 22 9.2 58 – Case series
[126] 161 MAA 18 6 59 22 Case series; OSA defined as AHI>5
Table 2 (continued)
Table 3 Summary of the outcome variables for studies listed in
Table 2
Variable Result No. of patients No. of studies
AHIbase 31 2,816 74
AHIappl 14 2,724 73
Response rate 21% 1,577 51
Success rate 54% 2,087 59
rate (%) rate (%)
Sleep Breath (2007) 11:1–22 7the success and response rates. The results are shown in
Table 5. We note that: (1) only patients with mild to
moderate sleep apnea were studied, (2) in two out of five
studies, the mean AHI was reduced by less than 50%, (3)
the success and response rates differ depending on the cut-
off value of the AHI (either five or ten), (4) for AHI=10
cut-off, the success rate is very similar to that of the
uncontrolled trials, but the response rate is lower. The
overall conclusion from these placebo-controlled crossover
trials is that oral appliances significantly improved sleep
apnea by reducing AHIbase from 25 to 14 with the
combined success and response rates of 64%.
One of the issues facing the effective use of oral
appliances is our ability to determine the appropriate degree
of protrusion necessary to resolve apnea and snoring. Until
recently, the only way to do so was to advance the
mandible forward as much as is tolerated by the patient,
to carry out polysomnography and hope that sleep apnea is
eliminated. Unlike CPAP, which may be controlled remote-
ly without waking the patient, the design of most appliances
requires removing it from patient’s mouth to change the
degree of protrusion. This wakes up the patient repeatedly,
resulting in a high probability that the titration study will be
unsuccessful, thus wasting valuable resources. However,
several “titration” protocols were described recently to
eliminate this problem. Fleury et al. [93] studied a protocol
where this titration was done at home, over a period of
several weeks, by advancing the mandible in 1 mm steps
and recording symptoms and ODI4. The effective protru-
sion was defined as that which results in either resolution in
symptoms or reduction in ODI4 to below ten. Using this
protocol, they were able to determine the protrusion, which
abolished sleep apnea in 64% of patients. Tsai et al. [94]
described a remotely controlled mandibular advancement
device, which could be titrated during the night in much the
same way that the CPAP is titrated. The mandible was
advanced remotely during the night in 1 mm increments
until respiratory events were eliminated. The success was
confirmed subsequently by carrying out all night poly-
somnography with the oral appliance set to the effective
protrusion determined during the titration study. The
positive predictive value of this titration protocol was
90%. On the other hand, Kuna et al. [114] found that the
titration protocol was not predictive of the response during
chronic use. In this investigation, 9 out of 21 patients with
OSA achieved reduction in AHI to less than 10 during
titration. However, none of them demonstrated the same
beneficial response during longer use of the appliance at
home with the effective protrusion determined during the
titration night. These results indicate that oral appliance
titration to predict the amount of mandibular advancement
required to reduce AHI to less than ten is still imprecise and
must be used with caution when determining the appliance
settings for home use. Nevertheless, the application of
titration protocols is a new and important development in
this field, which may improve the success of oral appliance
therapy by identifying patients who are likely to respond to
this treatment.
Predicting who will respond to the oral appliance
therapy is not yet possible, although there are several
studies where the differences in various parameters (mainly
weight and measures of airway size and collapsibility) were
studied in responders and non-responders [39, 116, 117].
The best correlates were always weight and oropharyngeal
airway size. However, although these studies provide useful
information, particularly with respect to the factors that
determine airway occlusion, they do not as yet provide us
with a method to predict who will respond to this therapy.
Table 4 Summary of results for complete studies
Results for complete studies
No. of studies 49





Table 5 Summary of results if randomized, crossover, placebo-controlled studies
Reference N AHIbase AHIappl Success rate (%) Response rate (%) Comments
[72] 24 30 14 38 25 For AHI=5 cut-off
54 17 For AHI=10 cutoff
[82] 73 27 12 36 27 For AHI=5 cutoff
[86] 20 38 23 30 10 Identical results for AHI=5 and AHI=10 cutoffs
[92]8 0 2 1 1 4 –– Tablet used as placebo; CPAP arm was also present
[122]7 3 2 4 1 23 6 – For AHI=5 cutoff
55 – For AHI=10 cutoff
Summary
270 25 14 35 24 For AHI=5 cutoff
50 14 For AHI=10 cutoff
8 Sleep Breath (2007) 11:1–22Oral appliances vs CPAP
Since CPAP remains as the “gold standard” treatment of
sleep apnea, the objective success rate of any other
treatment must be judged against it. There are seven
randomized, crossover studies, which compared mandibular
advancement appliances against CPAP. The results are
summarized in Table 6. We note that the findings of all
such studies are remarkably consistent—CPAP results in
better improvement in AHI than oral appliances. In all
studies except one, CPAP normalized the respiration,
bringing AHI to less than ten. In one study where AHI
with CPAP remained above ten, the highest pressure used
was 10 cm H2O, which is probably too low. However,
patients subjectively prefer oral appliances over CPAP. In
five out of seven studies, the patients expressed preference
for an oral appliance, in one study neither treatment was
preferred and in another study CPAP was preferred.
There are 2 additional investigations [87, 102], which
are not listed in Table 2 because of missing data regarding
follow-up sleep study. Nevertheless, these investigations
provide interesting information regarding the comparison of
oral appliances and CPAP. Smith and Stradling [87]
attempted to determine whether oral appliances can
substitute CPAP at least for 1 month. The authors found
that patients achieved similar reduction in ODI4 with CPAP
(from 29 to 1) as with oral appliance (from 29 to 4).
However, the patients did not like their oral appliance and
were refusing to use it. Out of 50 patients on CPAP who
were switched to oral appliance, only 11 were still using it
by end of 1 month. Most patients discontinued its use
because of discomfort, side effects, or treatment failure.
This study therefore favors CPAP. On the other hand,
McGown et al. [102] carried out a questionnaire survey of
126 patients treated with oral appliances. There were 41
patients who had tried both CPAP and oral appliance; 71%
preferred oral appliance, 19% preferred CPAP, and 10%
were unsure. This study favors oral appliance.
We conclude therefore that CPAP is more effective than
oral appliances in reducing AHI, but despite this, most
patients prefer oral appliances, undoubtedly because they
find them to be less cumbersome than CPAP.
Oral appliances vs other treatments
Since 1988 there were several studies [21, 53, 59, 64, 65,
68, 77, 79, 89, 90, 100], which compared either different
types of appliances, different degrees of protrusion or
different inter-incisal distance. The results are listed in
Table 7. Columns labeled “base” and “appl” show the
AHIbase and AHIappl, respectively. The column labeled
“comp” gives the AHI measured when other, i.e. “compar-
ison” treatment was used. The type of oral appliance
employed and the precise variables that were compared
are described in the last column. Since most studies
employed parallel group design, baseline AHI before
comparison treatment is also shown in this column.
Examination of the individual investigations reveals that
when oral compliances are compared to each other, either
two different appliances or the same appliance with
different degrees of protrusion or opening—it is cleat that
the efficacy (objective and subjective) is very much
dependent on the type of appliance and the degree of
advancement. This further emphasizes the point that oral
appliance therapy should be carried out by a dentist with
expertise in this field who is familiar with different types of
appliances and can select the most appropriate one for the
particular patient. There is no “best” appliance. The best
one is that which is comfortable to the patient and achieves
the desired efficacy.
There are several studies, mainly case series, comparing
oral appliances with surgical treatments. Comparisons with
Table 6 Randomized, crossover, CPAP vs oral appliance studies
Reference N AHIbase AHIappl AHI
CPAP
Comments
[46] 19 20 10 4 68% of patients were satisfied with OA vs 62% with CPAP (p<0.05)
[45] 21 34 20 11 OA preferred
[50] 20 25 14 4 65% preferred OA, 30% preferred CPAP
[84]2 0 1 8 1 4 4“Patients identified oral appliance as being easier to use”
[85]4 8 3 1 1 5 8“Neither treatment was significantly preferred by patients”
[88]2 4 2 2 83“...17 out of the 21 subjects who completed both arms of the study preferred the MAS”
[92]8 0 2 1 1 4 5“Although subjects reported that CPAP was the most difficult treatment to use, they felt that
it was the most effective and overall preferred it to the MAS, which was in turn preferred
to placebo”
Summary
232 24 14 6 Oral appliance preferred overall
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appliances. At 1 year follow-up, sleep apnea was resolved
(AHI<10) in 78% of the oral appliances group and 51% of
the UPPP group. With longer follow-up, this success rate
deteriorates. At 4 years follow-up, 63% of the oral
appliance group and 33% of the UPPP group continue to
have AHI<10. One parallel group study of oral appliance
(TRD) vs radiofrequency ablation (somnoplasty) found that
both treatments significantly reduced sleep time spent with
loud snoring. However, there was no difference between
oral appliance and somnoplasty [21]. A recent small case
series of 4 patients (out of 43 treated with oral appliances)
who elected maxillomandibular advancement surgery [121]
showed that initial AHI=50 dropped to 12 with oral
appliance and to 2 after surgery.
Oral appliances for the treatment of snoring
Although everyone can recognize snoring, it proved to be
a very elusive entity to measure objectively. One can
define the sound properties (i.e. frequency spectrum and
intensity), relationship to breathing (i.e. waxing and
waning sound, generally during inspiration), and measure
this sound during sleep. However, subjective recognition
of sound, which satisfies some pre-defined “snoring”
criteria as de facto snoring depends very much on the
listener. This is contrary to the case of apneas or even
hypopneas, whose definition is independent of any
subjective perception. These difficulties with the definition
of snoring are the reasons why objective measurement of
sound is seldom a routine part of polysomnography.
However, snoring is the cardinal symptom of sleep apnea.
In fact, it is frequently the only reason why these patients
come to the sleep clinic in the first place. Consequently,
when polysomnography does not reveal sleep apnea in
these patients, the physician still has to deal with their
snoring. Unfortunately, this is often ignored by physicians.
The most frequent scenario is that a patient is referred to
a sleep specialist because of snoring, polysomnography is
carried out, no sleep apnea is found, the patient is reassured,
advised to loose weight, stop smoking and drinking
alcohol, embark on an exercise program, and discharged
from the clinic. Sometimes this advice, dispensed in the
form of preprinted sheets, is given also to non-obese non-
smokers. Clearly, the patient leaves unhappy, the referring
physician is dissatisfied with the help received from the
specialist and nothing was accomplished to justify the
expense incurred in the process of investigations. For
apneic snorers, the problem is simpler because treatment
with CPAP will abolish snoring.
Non-apneic snorers without daytime symptoms do not
tolerate CPAP well. Many of them will agree to try it, but
the majority will stop using it after a short time (generally a
few weeks to a few months). Oral appliances therefore
constitute an attractive alternative for the treatment of
Table 7 Studies comparing oral appliances to treatments other than CPAP
Reference N AHI Comments
Base Appl Comp
[53] 23 4 3.5 0.8 Parallel groups; OA=MAA with max protrusion, comp=MAA with 70% of maximum protrusion,
but double inter-incisal opening; baseline AHI=7 for comp group
[59] 41 18 6 10 Parallel groups; OA=MAA, comp=UPPP; prospective, randomized, baseline AHI=20 for UPPP
group; results at 12 months
[64] 37 26 17 11 Single group; OA=MAA with 2 mm protrusion, comp=6 mm protrusion; ODI4 recorded
[65] 5 50 30 44 Single group; OA=MAA, comp=TRD; only 5/8 patients agreed to try TRD
[65] 2 47 35 57 Single group; comp=SPL; only 2/8 patients agreed to try SPL
[68] 24 23 9 8 Crossover, randomized; OA=MAA (Herbst), comp=monoblock
[21] 10 5 5 10 Parallel groups: OA=TRD, comp=somnoplasty; baseline RDI same for both groups
[77] 23 21 8 10 Crossover, randomized; OA=MAA with 4 mm inter-incisal opening, comp=MAA with 14 mm
opening
[79] 72 18 7 14 Parallel groups, randomized; OA=MAA, comp=UPPP; baseline AHI for UPPP group=20; results
at 4 years
[89] 84 47 17 16 Parallel groups, randomized; OA=MAA with 50% protrusion, comp=MAA with 75% protrusion;
baseline AHI for 75% group=50; results at 6 months
[90] 55 16 6 6 Parallel groups, randomized; OA=MAA with 50% protrusion, comp=MAA with 75% protrusion;
baseline AHI for 75% group=19; results at 12 months
[100] 16 46 25 34 Crossover, prospective, randomized; OA=Herbst, comp=Twin Block; median AHIs reported
Summary
392 26 11 12
10 Sleep Breath (2007) 11:1–22snoring. In fact, they were originally invented precisely for
that reason.
Many, but not all investigations of oral appliances
comment on their efficacy in reducing snoring. Recogniz-
ing that the objective measurement of sound during
polysomnography may not correspond to the perception
of this sound as being snoring—subjective assessment is
generally employed. This assessment varies from simply
asking an informal question “is your snoring improved?”,t o
employing a more formal method, which is usually a visual
scale (analogue or digital) to rate snoring. Unfortunately, in
almost all studies, the answers to these subjective questions
are given by the snorers who of course are unaware of their
snoring, rather than by the bed partner. Although snoring is
recorded as the patient’s chief complaint, it is really not the
patient’s complaint at all—it is the complaint of the bed
partner. The implicit assumption in most investigations is
that the patient’s responses reflect those of the bed partner.
Nevertheless, the efficacy of snoring treatment must be
assessed by the same bed partner, not by the snorer. This
poses great logistical problems in carrying out appropriate
investigations. However, some support for this assumption
of equivalence between the responses of snorers and
listeners is provided by a recent questionnaire data of Bates
and McDonald [115] who found that 70% of snorers and
70% of the bed partners reported improvement in snoring
after using a mandibular repositioning splint for 3 months.
Table 8 lists 47 investigations, which utilized oral
appliances. The only common feature among these inves-
tigations, and the reason why other investigations were not
included—is that all of the listed ones contained a specific
comment regarding snoring. The types of snoring assess-
ment carried out in these investigations ranged from an
informal question about snoring to rating the snoring using
a visual scale and objective sound measurement together
with subjective assessment. Very few investigations includ-
ed objective measurement of snoring. Investigations with
subjective assessment of snoring using questionnaires form
a very inhomogeneous group because they used different
types of questionnaires with different rating methods.
Given these differences in methodology, it is not possible
to rigorously summarize the results. However, certain
generalizations can be made.
First, the majority of the investigations concluded that
oral appliances are beneficial in reducing snoring in the
majority of patients. Second, all of the randomized,
placebo-appliance-controlled studies except one [86] found
significant reduction in snoring, independently of whether it
was assessed objectively or subjectively. Johnston et al.
[86] did not find a significant difference in either the
loudness (measured using the VAS 0 to 5 scale) or the
frequency (nights/week) of snoring. However, an earlier
study from the same group [75], employing similar
methodology but different patient population (non-apneic
snorers), did demonstrate significant reduction in snoring.
This further illustrates the difficulties with subjective
assessment of snoring in different patient populations. Even
in the same patient population, there is a discrepancy
between objective measurement and subjective perception,
as found by Lawton et al. [100].
We shall present the summary of the individual inves-
tigations listed in Table 8 as follows. First, we selected only
those investigations where a numerical value describing
snoring with and without appliance was given. These
results are shown in Table 9. There are 18 studies involving
529 patients. All, except one [21], employed the mandib-
ular adjustment appliance. All of these investigations give a
“number” to quantify snoring. We note the diversity of
measurement of snoring in each study—the “number” in
Table 9 represents either a VAS score, number of snorers/h (or
min) of sleep, amount of time spent with loud snoring per
hour of sleep or per night, number of nights per week spent
with disturbing snoring or noise level, etc. However, we can
calculate the percent change between the baseline night and
the “with appliance” night, displayed in the last column of
Table 9. We note that despite the diversity of snoring
measurements, in all investigations the percent change is
negative—which indicates that the investigators always found
reduction in snoring with oral appliances. The mean reduction
in snoring using the pooled data was 45%.
Effect of oral appliances on daytime function
In assessing the effect of oral appliances on sleep apnea
syndrome, it is not sufficient to focus only on the apnea/
hypopnea index or snoring. We must also demonstrate the
effect of this treatment on daytime function, which is
almost always compromised in patients with sleep apnea
and sometimes in non-apneic snorers also. There are several
tools used to assess daytime function, but there is little
consistency in using these tools in investigations involving
oral appliances.
Table 10 summarizes the results of investigations where
some assessment of daytime function was performed, no
matter how primitive. The methods of assessment differ in
each investigation. Some relied on answers to questions
regarding daytime sleepiness and tiredness, others utilized
visual scales, yet other investigations measured response
time to various tasks, etc. After 1995, the majority of
investigations employed the Epworth sleepiness score
(ESS). The results generally show improvement in daytime
symptoms with oral appliances.
Because of the diversity of methods assessing daytime
function, it is difficult to pool and summarize the individual
data. One way of doing this is to select only those
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[27] 5 TRD “Snoring decreased or completely disappeared”
[28] 12 MAA “8/12 reported substantial reduction of sonorous sleeping
[31] 1 MAA “After appliance insertion...immediate...reduction in snoring”
[34] 68 MAA 8.5 1.5 Snoring severity assessed subjectively (max score=10); snoring eliminated in 42%
[35] 12 MAA Snoring reduced, although never eliminated, in 79%
[38] 24 MAA 7.6 Snoring on a scale from 0 to 10; improvement also on a scale from 0 to 10—result=4.3
[42] 51 MAA 9.4 8.2 No. of snores/min; snoring eliminated in 8/51, improved in 43/51
[46] 25 MAA Snoring less than “moderate” in 19/25 pts
[47] 23 MAA “...20/23 patients (87%) reported subjective improvement...in snoring”
[49] 23 TRD “Visual analog scores of snoring...were also reduced significantly” in 6/23 (23%) subjects
[53] 23 MAA “...loud snore duration was reduced from a median of 27.1 min to 11.4 min”
[54] 44 MAA “Snoring was satisfactorily reduced in” 37/44 patients (84%)
[57] 15 MAA 193 20 Median snores/h given; snoring loudness and time spent snoring also improved
[102] 132 MAA “Snoring was reported...to be satisfactorily controlled in 107 (81%)...
[58] 14 MAA 6/14—no snoring; 8/14—mild snoring
[59] 41 MAA 0.7 0.5 No. of snores/h of sleep at baseline and 12 months follow-up (NS)
[60] 75 MAA “Dramatic reduction in the attributes of snoring was achieved”
[66] 112 MAA 76/112 (68%) snoring either eliminated or acceptable
[68] 24 MAA 50 33 No of snores/h sleep; results for Herbst appliance; 19/20 disturbed by snoring at baseline, vs 9/20
with appliance
[21] 10 TRD 11 3 Percent of time spent in loud snoring
[69] 39 MAA “Time with snoring dropped significantly from 16.3% to 6.6%”
[71] 22 MAA Snoring eliminated in 13/22, significantly reduced in 5/22; success rate=18/22 (82%)
[104] 53 MAA Questionnaire survey; 27/53 were still using the device at 1 year, and 22 were satisfied (42%)
[105] 21 MAA Questionnaire survey; 22 patients fitted with appliance; 43% thought it reduced snoring, 48%—no
benefit
[102] 126 MAA Questionnaire survey; “80 out of 94 patients reported improvement in snoring”
[73] 22 MAA 59 24 No. of snores/h of sleep; subjective improvement as well
[75] 25 MAA 3.4 1.8 Randomized controlled vs placebo-appliance; non-apneic snorers; frequency of snoring (nights/
week), p<0.05; 15/25 greatly improved with MAA vs 2/25 with placebo
[76] 33 MAA “19/33 had short-term satisfactory treatment results with the device”
[72] 28 MAA 402 242 Randomized, controlled vs placebo-appliance; snores/h of sleep (p<0.005); mean snoring intensity
significantly reduced; “the majority of patients reported substantial improvement in snoring (70%)
[82] 73 MAA 366 207 Randomized, controlled vs placebo-appliance; snores/h of sleep (p<0.0001); mean and maximum
snoring intensity significantly reduced; significant subjective reduction in snoring
[86] 16 MAA 3.1 2.6 Randomized, placebo-controlled crossover; frequency of snoring (nights/week) (p=0.07); no
significant difference in loudness of snoring
[79] 32 MAA 0.7 0.5 Duration of snoring/h of sleep (p<0.01)
[80] 26 MAA “The patients and their bed partners thought that...snoring...improved...”
[84] 20 MAA 55 36 Snoring epochs/h (p<0.01); randomized crossover study vs CPAP
[89] 40 MAA 0.86 0.57 Duration of snoring/h of sleep (p<0.001); comparison of two protrusions; results for 75%
protrusion group
[90] 26 MAA Comparison of two protrusions; results for 75% protrusion group; “problems with apneas and
snoring...decreased by...79%...”
[91] 25 MAA “...snoring...patients have benefited from oral appliance therapy and their spouses will testify to the
same”
[93] 44 MAA Subjective assessment; “on average, a mean reduction of 90% of the intensity of snoring was
reported by the patients”
[95] 619 MAA “It is estimated that 50% of the 619 snorers and sleep apnea patients had treatment success or
subjective beneficial effects...”
[96] 11 MAA 240 75 Noise level measured; “10 out of 11 subjects had a significant reduction in snore noise sound
level...”
[97] 20 MAA 9.0 6.8 VAS 0–10 scale (p<0.05); result at 6 months follow-up; subjectively 14/20 were satisfied
[106] 110 MAA Questionnaire survey; 37 out of 77 patients who returned questionnaire thought snoring was
12 Sleep Breath (2007) 11:1–22investigations, which employed identical methods of
assessment and summarize the mean results, as was done
in the previous tables. The most common single way of
assessing daytime function in most investigations was the
ESS. These investigations are listed in Table 11. There are
23 of them involving a total of 962 patients. However, not
all investigations could be used in calculating pooled data.
We rejected four investigations [19, 53, 98, 100], involving
108 patients where only the median and not the mean
values of the ESS were reported. Consequently, we are left
with 19 investigations involving 854 patients. As a group,
these patients were only mildly sleepy with the mean ESS
of 11.2. In all investigations, the ESS dropped with the use
of oral appliances. For the entire group, there was a
significant reduction in the ESS from 11.2 to 7.8.
In two investigations [85, 86], both randomized, cross-
over and controlled (one vs placebo and another one vs
CPAP) reduction in ESS was not significant. Engleman et
al. [85] carried out a very extensive study of daytime
function comparing the effect of oral appliance to CPAP.
Functional assessment included maintenance of wakeful-
ness test, measures of daytime sleepiness and symptoms,
measures of well-being (using the SF-36 questionnaire,
HADS anxiety and depression score), and cognitive
performance. The results favored CPAP in 7 out of 21
variables (including the ESS, AHI, effectiveness and
symptoms), and showed no difference between CPAP and
oral appliance in other variables (including the maintenance
of wakefulness tests, cognitive performance and treatment
preference). Johnston et al. [75, 86] compared oral
Table 9 Studies with measurement of snoring
Reference N Snoring measure Explanation of snoring measurement Percent change
Base Appl
[34] 68 8.5 1.5 Visual analogue scale 0–10 −82
[42] 51 9.4 8.2 Number of snores/min −13
[57] 15 193 20 Number of snores/h −90
[59] 41 0.7 0.5 Number of snores/h −29
[68] 24 50 33 Number of snores/h −34
[21] 10 11 3 Percent of sleep time spent in loud snoring −73
[73] 22 59 24 Number of snores/h −59
[75] 25 3.4 1.8 Nights/per week with disturbing snoring −47
[72] 28 402 242 Number of snores/h −40
[82] 73 366 207 Number of snores/h −43
[86] 16 3.1 2.6 Nights/per week with disturbing snoring −16
[79] 32 0.7 0.5 Minutes of snoring/h of sleep −29
[84] 20 55 36 Snoring epochs/h of sleep −35
[89] 40 0.86 0.57 Minutes of snoring/h of sleep −34
[96] 11 240 75 Noise level −69
[97] 20 9.0 6.8 Visual analogue scale 0–10 −24
[99] 17 53 16 Total snoring time −66
[100] 16 144 64 Number of snores/h of sleep −56
Summary
529 −45





[99] 17 MAA 53 16 p=0.02; snoring time
[19] 25 MAA 15/25 snoring markedly improved
[100] 16 MAA 144 64 Snores/h; however, VAS 0–10 scale–no difference
[101] 251 MAA 75% of 191 users of appliance reported control of snoring; 43% of non-users of appliance also
thought snoring was controlled
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Reference N Test or question Result Comments
Base Appl
[11] 14 Daytime function –– 14/14 reported improvement
[25] 7 Sleepiness –– Improved
[26] 44 Vigilance 0.5 0.4 Reaction time (p<0.05)
[27] 5 Daytime sleepiness –– “ Daytime somnolence was eliminated or diminished markedly”
[28] 12 Daytime somnolence –– “ 9/12 patients reported increased alertness and/or reduction in daytime
sleepiness”
[34] 63 Prevalence of daytime
sleepiness
–– “ 51% of these patients reported no more sleepiness with orthosis use”
[35] 12 Daytime sleepiness –– “ Daytime sleepiness was improved...in all but two patients”
[33] 14 Symptom score (including
sleepiness)
5.5 1.1 Significant(p<0.001) improvement in daytime symptoms
[38] 24 Sleepiness and
improvement using 0–10
Likert scale
6.4 – Improvement on 0–10 Likert scale=4.5 at 36 months
[42] 51 Patients tired; patients
sleepy
44 30
[44] 30 No. of mistakes in vigilance
test
7.6 3.7 p<0.05
[45] 21 EDS daytime symptoms 2.4 1.6 1–5 scale; p<0.0001) for all symptoms
[46] 25 Prevalence of EDS 84% 40% p<0.005; significant reduction in prevalence of other symptoms
[47] 23 Patients with EDS 23 20
[49] 14 EDS using VAS –– Reduction in scores (p<0.05) in 6 of 14 patients who were compliant with
treatment
[50] 20 ESS 10.3 4.7 p<0.05; EDS improved in 13/20 patients
[53] 14 ESS 12 4.5 Median score, p<0.005
[53] 9 ESS 7 4 Median score, p<0.005
[54] 44 Patients with daytime
sleepiness
44 34




[59] 41 Daytime sleepiness on 1–5
scale
–– Prospective, randomized, UPPP group and OA group; “in comparison
with their baseline values...a significant (p<0.001) reduction in
subjective daytime sleepiness”
[60] 75 ESS 11 7 p<0.0005
[107] 90 Quality of life (vitality+
contentment+sleep)
129 94 Significant improvement compared to baseline; two parallel groups—OA
vs UPPP; no difference in vitality and sleep
[66] 112 No. of patients “refreshed
by sleep”
– 66/114 “Most of the regular users had an improvement in their quality of sleep
and day time somnolence...”
[68] 24 ESS 13.1 8.6 p<0.001; identical result for two different MAAs
[71] 22 No. of patients whose
sleepiness disappeared
17/22 “17 (85%) of 22 patients reported subjective improvement in excessive
daytime sleepiness”
[72] 24 ESS 10.1 3.9 p<0.01
[73] 22 ESS 12 7.5 p<0.05 at 12 to 30 months follow-up
[75] 24 ESS 7.5 6.5 p<0.01; randomizedplacebo-controlledcrossover trialofnon-apneicsnorers
[76] 19 No. of patients reporting
reduction in EDS
13/19
[77] 23 ESS 18 12 p<0.0001; identical result for two different MAAs
[81] 26 Questionnaire: EDS 1.61 Scale from −3 (maximum deterioration) to +3 (maximum improvement)
[87] 34 ESS 13 7.7 After 28 days, only 11 patients continued to wear MAA; initial ESS based
on 34 patients, final—on 11
[88] 24 ESS 13.4 9.0 p<0.001; randomized crossover vs CPAP
[85] 48 ESS 14 12 NS; randomized crossover vs CPAP; extensive tests of daytime function;
“these results do not support these MRS devices as first-line treatment
for sleepy patients with SAHS”
14 Sleep Breath (2007) 11:1–22appliance to placebo, but did not carry extensive inves-
tigations of daytime function—only the ESS and a 5-point
scale describing how refreshed the patients felt in the
morning. The authors found significant improvement
compared to placebo, but only in non-apneic snorers [75],
not in patients with sleep apnea [86].
In all other randomized, crossover, controlled studies
there was a statistically significant improvement in the ESS,
but not in other subjective measures of daytime perfor-
mance. In fact, none of the studies demonstrated a
significant improvement in all of the subjective outcomes
studied. This is not surprising because almost all studies
comparing placebo treatment with active treatment, no
matter what it is, always demonstrate a significant placebo
effect.
Probably the most complete assessment of neuropsycho-
logical function was carried out by Naismith et al. [122]i n
a prospective, randomized, placebo-appliance-controlled
study of 73 patients treated for 4 weeks. The authors
demonstrated significant improvement in the measures of
self-reported sleepiness, fatigue and energy levels, but no
improvement in the measured speed/vigilance (except for
the improved reaction time), attention/working/verbal mem-
ory or visuospatial/executive functioning. Walker-Engstrom
et al. [107] compared the quality of life in two parallel
groups of patients with sleep apnea 1 year after treatment
with either oral appliance or UPPP. The ESS was not
measured, but there was other extensive assessment of three
quality of life dimensions (vitality, contentment and sleep).
Both groups improved compared to the baseline. There was
no difference in vitality and sleep dimensions between the
two groups, but the UPPP group was more content than the
oral appliance group.
The effect of oral appliances on daytime function was
not studied as fully and extensively as for CPAP. For
example, there are no studies comparing driving simulator
performance in patients treated with oral appliance, no
studies comparing multiple sleep latency or maintenance of
wakefulness. Recognizing the limited nature of the data—
the conclusion from all of the investigations taken as a
group must be that oral appliances improve daytime
function, although they are not necessarily superior or
consistently preferred than other treatments such as CPAP
and UPPP.
Effect of oral appliances on vascular disease
Numerous investigations examined the relationship be-
tween sleep apnea and vascular events, such as coronary
artery disease, hypertension, and cerebro-vascular disease.
Fewer, but still many investigations were carried out to
Reference N Test or question Result Comments
Base Appl
[82] 73 ESS 11 9 p<0.0001); “the proportion of patients with normal subjective sleepiness
was significantly higher with the MAS than with the control device (82
vs 62%, p<0.01), but this was not so for objective sleepiness (48% vs
34%, p=0.08)”
[86] 18 ESS 12.6 11.6 NS; randomized placebo-controlled crossover trial of apneic snorers
[89] 42 ESS 11.5 7.5 p<0.001; prospective randomized comparing 50% and 75% protrusion;
result for 75%; initial value—42 patients, final value—40
[90] 55 Questionnaire: EDS Randomized comparison of two protrusions; “82% of patients in 50%
group (n=29) and 84% in 75% group (n=26) reported a decrease in
daytime sleepiness”
[96] 29 ESS 9.4 6.9 p<0.001
[92] 80 ESS 10.2 9.2 p<0.001; randomized vs placebo pill and CPAP
[93] 40 ESS 12.0 5.1 p<0.001
[97] 20 ESS 8.8 5.4 p<0.05
[98] 42 ESS 10 6 p<0.02; median values
[19] 27 ESS 9 6 p<0.001; median values
[100] 16 ESS 10 8 Median values
[101] 161 ESS 11 7 In users of OA; in 90 non-users—ESS fell from 11.1 to 8.1
[115] 67 Concentration, energy
levels, sleep quality, ESS
9.7 – ESS given; 29–59% of responders reported improvement
[122] 73 ESS and full battery of
neuropsychological
measures
5.0 4.2 Total score of all self-report measures given; prospective, randomized,
placebo-appliance-controlled 4 weeks study
Table 10 (continued)
Base Appl
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CPAP on changes in these conditions.
Quite the opposite situation is seen regarding the effect
of oral appliances on vascular disease. There are only three
studies examining the effect of the treatment of sleep apnea
with oral appliance on blood pressure. Both studies
employed the randomized, controlled, crossover design.
The first study was carried out by Gotsopoulos et al. [113]
specifically for the purpose of examining the effect of
4 weeks treatment with a mandibular advancement splint on
24-h blood pressure in 67 patients with sleep apnea (mean
AHI=27). There was approximately 3.5 mmHg drop in the
systolic and diastolic blood pressure with treatment, but
only during wakefulness. There was no change in blood
pressure during sleep. The second study by Barnes et al.
[92] compared the effect of 3 months treatment with oral
appliance to CPAP and placebo (a tablet). In 110 patients
with sleep apnea (mean AHI=21), the 24 h blood pressure
was measured. Treatment with oral appliance (but not with
CPAP or placebo tablet) resulted in the significant reduction
in nighttime diastolic blood pressure by 2.2 mmHg. There
were no changes in diastolic blood pressure during
wakefulness and no changes in systolic blood pressure
either during wakefulness or sleep. The third study was
carried out by Yoshida [126] who measured blood pressure
in 161 patients with sleep apnea before and after 60 days of
treatment with oral appliance. There was a statistically
significant drop in blood pressure from 132.0/82.1 to 127.5/
79.2 mmHg. Regression analysis demonstrated weak, but
significant correlation between the mean arterial and
baseline blood pressures and the reduction in AHI. This
area of investigation is still in its infancy, and undoubtedly,
more results will be forthcoming in the future.
There are no rigorous studies of the effect of oral
appliances on other vascular diseases. Eskafi et al. [99]
carried out a single night, unattended, home sleep study in
17 patients with sleep apnea (mean AHI=25) and conges-
tive heart failure with periodic breathing before and after
Table 11 Functional assessment using ESS
Reference N ESS Comments
Base Appl
[50] 20 10.3 4.7 p<0.05; EDS improved in 13/20 patients
[53] 14 12 4.5 Median score, p<0.005
[53] 9 7 4 Median score, p<0.005
[60]7 5 1 1 7 p<0.0005
[68] 24 13.1 8.6 p<0.001; identical result for two different MAAs;
[72] 24 10.1 3.9 p<0.01
[73] 22 12 7.5 p<0.05 at 12 to 30 months follow-up
[75] 24 7.5 6.5 p<0.01; randomized placebo-controlled crossover trial of non-apneic snorers
[77]2 3 1 8 1 2 p<0.0001; identical result for two different MAAs
[87] 34 13 7.7 After 28 days, only 11 patients continued to wear MAA; initial ESS based on 34 patients, final ESS—on 11
[88] 24 13.4 9.0 p<0.001; randomized crossover vs CPAP
[85] 48 14 12 NS; randomized crossover vs CPAP; extensive tests of daytime function; “these results do not support these
MRS devices as first-line treatment for sleepy patients with SAHS”
[82]7 3 1 1 9 p<0.0001); “the proportion of patients with normal subjective sleepiness was significantly higher with the
MAS than with the control device (82% vs 62%, p<0.01), but this was not so for objective sleepiness (48%
vs 34%, p=0.08)
[86] 18 12.6 11.6 NS; randomized placebo-controlled crossover trial of apneic snorers
[89] 42 11.5 7.5 p<0.001; prospective randomized comparing 50% and 75% protrusion; result for 75%; initial n=42
patients, final n=40 patients
[96] 29 9.4 6.9 p<0.001)
[92] 80 10.2 9.2 p<0.001; randomized vs placebo pill and CPAP
[93] 40 12.0 5.1 p<0.001
[97] 20 8.8 5.4 p<0.05
[98]4 2 1 0 6 p<0.02; median values
[19]2 7 9 6 p<0.001; median values
[100] 16 10 8 Median values
[101] 161 11 7 Result for users of OA; in 90 non-users—ESS fell from 11.1 to 8.1
[122] 73 9.1 7.1 Prospective, randomized, placebo-appliance-controlled 4 weeks study
Summary
854 11.2 7.8 References 19, 53, 98–100 were excluded (no mean values were given)
16 Sleep Breath (2007) 11:1–22intervention with a mandibular advancement device. The
authors found improvement in sleep apnea (mean AHI
reduced from 25 to 15), but no improvement in periodic
breathing or left ventricular ejection fraction after 6 months
of treatment.
There is not enough evidence at the present time to draw
any conclusions regarding the effect of oral appliance
therapy on vascular disease. This remains a very interesting
area of investigation. Given the differences in intra-thoracic
pressure as a consequence of CPAP vs oral appliance, it is
possible that results obtained with oral appliances therapy
will be different from those obtained with positive pressure
therapy.
Side effects
Almost every study describing oral appliances comments
on the side effects voiced by patients. The type of side
effects and their frequency depend on the questions asked,
the rating scale, the number of patients in the study, etc.
Some studies specifically focused on the side effects and
compliance with treatment [101, 102, 106, 110], others
simply asked a few questions about the side effects.
Table 12 summarizes some of the common side effects;
there is also a reference to the study, which reported the
highest frequency of this particular side effect.
Excessive salivation, mouth, and teeth discomfort are the
most common side effects reported. However, patients
seldom consider these side effects troublesome. Provided
that this complaint is addressed by the dentist and the
appliance is adjusted, they continue to use it. In many cases
the side effects are transient and disappear with continued
use. When patients stop wearing the oral appliances it is
mainly because of ineffectiveness, rather than because of
side effects, although in some studies [95, 101]u pt o4 0 –
50% of patients discontinued the use of the appliances
because of the side effects. One study [39], involving only
14 patients all using the Herbst appliance, reported that
none of the patients had any side effects! The conclusion,
based on the results of most studies, is that when oral
appliances are properly constructed by the dentist with
expertise in this area, they are relatively comfortable in the
majority of patients.
There are also dental effects of oral appliances. It is still
not entirely clear if long-term use of oral appliances will
lead to permanent adverse dental changes, particularly
when used in children. There are several studies addressing
various dental–skeletal changes of oral appliances using
various imaging techniques. One of the most common
effects, commented upon in many studies, is the degree of
vertical and horizontal overlap of the teeth (overjet and
overbite, respectively). These results are summarized in
Table 13. There are 11 distinct studies, involving 694
patients with mean follow-up time of 43 months. Two
studies [78, 118] were rejected because only the median
results were given, and one study [127] was rejected
because no mean values for overjet and overbite were
shown, only changes in these parameters over a period of
3 years. A summary of the remaining data involving 389
patients with mean follow-up of 39 months shows that the
overbite is reduced from 3.8 to 2.4 mm and the overjet is
reduced from 4.0 to 2.7 mm. It is clear that dental–skeletal
effects of oral appliances are certainly present, but the long-
term results and their clinical significance are unknown at
this time. The recent studies of Marklund [118] and de
Almeida et al. [119] described patients who were using
mandibular advancement appliances for more than 5 years.
Their results suggest that orthodontic changes (1) are
variable (favorable in some and unfavorable in others), (2)
are clinically relevant, and (3) might be predictable from
the initial dental characteristics of the patients and the type
of device.
Compliance
Compliance with oral appliances depends strictly on the
balance between the perception of benefit and side effects.
Most patients treated with oral appliances have relatively
mild sleep apnea and relatively few daytime symptoms; the
main reason for treatment was snoring. Consequently, the
perception of benefit is generally that of the bed partner,
whereas the side effects are experienced by the wearer of
the appliance. This is why the assessment of compliance is
a complex issue. In some cases, although the appliance is
quite comfortable, the patient may stop wearing it if the bed
partner is no longer present or no longer complains of
snoring.
Table 12 Patient reported side effects of oral appliances




Difficulty in chewing 11–19 [101]
Excessive salivation 9–60 [106]
Dry mouth 14–86 [73]
Tooth discomfort 11–59 [73]
Tongue discomfort 6–8[ 101]
Jaw discomfort 8–41 [73]
Gum discomfort 1–2[ 101]
Headache 2–27 [89]
Occlusive changes 41 [76]
TMJ pain 37 [102]
Masseter muscle pain 45 [66]
No side effects at all 100 [39]; 14 subjects
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compliance data. All of them except one [49] employed
mandibular advancement devices. There is a very wide
variability between individual investigations—from as little
as 4% to as high as 76% at the end of 1 year.
The largest study is that of de Almeida et al. [101]. It is
based on a mail survey of 544 patients, of whom 251
returned the questionnaire on the average of almost 6 years
after the construction of the appliance. The majority of
patients were fitted with MAAs, although some had TRDs.
At the time of follow-up, 161 patients continued to use the
appliance. Assuming “the worse case scenario” (i.e. all
those who did not return the questionnaire were no longer
using the appliance) the compliance rate is 161/544=30%,
while in the “best case scenario” the compliance rate is 161/
251=64%. Among those who used the appliance, 82% of
bed partners were satisfied with this treatment; even among
the non-users of appliances, 46% of bed partners were
satisfied. The main reasons for discontinuing the use of the
appliance were discomfort (44%) and perception of little or
no benefit (34%).
Pooled data summarizing all 21 reviewed studies
involving 3,107 patients, showed that at the end of
33 months, 56–68% of them continued to wear the
appliance.




Base F/U Base F/U
[39] 19 13 4.0 −3.0 2.9 6.3 Herbst appliance
[108] 32 24 4.5 4.1 3.6 3.5
[71] 22 6 5.97 1.08 3.97 −8.01 After correction for magnification error
[109] 87 30 4.25 3.19 4.09 3.07 Effects evident already at 6 months
[73] 22 14 3.3 3.1 4.0 3.6 Median results at follow-up
[110] 47 28 3.9 3.6 3.2 2.8 Significantly larger changes compared to reference group
[110] 28 31 4.5 3.9 3.8 3.3 Ibid
[81] 34 30 4.4 3.1 3.6 2.5
[111] 30 48 3.5 3.1 4.3 3.8 NS; compared to UPPP
[112] 20 30 3.84 2.63 4.43 2.61 Effects evident at 6 months
[90]2 9 1 2 ––2.5 2.4 NS; for 50% protrusion; same for 75% protrusion
[118] 187 60 3.5 3.0 3.0 2.80 Median values; overbite change NS; orthodontic side effect increase with
treatment time and more frequent use
[119] 31 89 2.12 0.45 2.7 0.46 70 patients followed-up for 7.4 years; measurements made from models;
“unfavorable change” group
[119] 10 89 2.75 2.9 4.45 3.87 As above; “no change” group
[119] 29 89 3.95 2.72 4.47 2.52 As above; “favorable change” group
[127]6 7 3 6 –––– Only changes, but not baseline values in overjet and overbite are given (−0.8
and −0.6, respectively over 3 years); small but significant reductions
observed mainly during the first year
Summary
389 39 4.0 2.6 References [73, 118] were excluded
418 37 3.7 2.4
Table 14 Compliance with oral appliances
Reference N F/U (months) Compliance (%)
[34]7 1 7 7 1 –75
[35]2 4 1 2 4 –5
[38]2 4 3 6 5 0 –75
[39]1 9 2 4 6 8 –93
[47]2 9 4 1 5 5 –70
[49]2 3 6 2 1
[103] 191 31 52–76
[107]4 5 1 2 8 2
[66] 173 9 45–70
[70] 256 31 90
[71] 22 6 100
[76]3 3 6 2 5 8
[102] 166 22 42–56
[79]4 5 4 8 6 2
[81]8 6 1 8 –24 30–53
[89]7 4 1 2 7 2 –76
[106] 110 22 40–57
[95] 630 12 75–76
[101] 544 68 30–64
[115]9 2 3 6 8
[118] 450 60 56
Summary
3,107 33 56–68
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Oral appliances used to date constitute a relatively
heterogeneous group of devices for the treatment of sleep
apnea and non-apneic snoring. It is this heterogeneity,
which partly accounts for the variability in their benefit and
side effects. Another reason for variability is the diverse
methodology employed in different studies. The evidence
available at present indicates that oral appliances success-
fully “cure” mild-to-moderate sleep apnea in 40–50% of
patients, and significantly improve it in additional 10–20%.
They reduce, but do not eliminate snoring. Side effects are
common, but are relatively minor. Provided that the
appliances are constructed by qualified dentists, 50–70%
of patients continue to use them for several years. Their
effectiveness is inferior to CPAP. It is similar to surgical
procedures, but these are invasive, (although not particu-
larly dangerous) and irreversible. The effect of oral
appliances on the vascular consequences of sleep apnea is
not known.
The place of oral appliances in the spectrum of treatment
options for apneic and non-apneic snorers was extensively
discussed in various reviews and guidelines, including the
most recent report by the American Academy of Sleep
Medicine [124, 125]. The current review does not alter
those conclusions. It simply illustrates the marked variabil-
ity of individual responses to oral appliance therapy, and
therefore the necessity to approach each patient on an
individual basis. Patients with sleep apnea should be
informed about all treatment options. In some cases, the
decision is simple; after informing patients about all
available options, a strong and clear recommendation can
be given by the health care practitioner. In other cases, the
decision regarding treatment is arrived at only after
individual consideration of all the factors—urgency of
clinical situation, reimbursement plan available to patient,
risk factors and the patient’s ability or motivation to modify
them, patient’s preferences, and a possibility of having a
trial of treatment with oral appliance and CPAP. There are
patients with severe sleep apnea successfully treated with
oral appliances, just as there are non-apneic snorers with or
without upper airway resistance syndrome, successfully
treated with CPAP. The decision regarding treatment in
each individual patient is best made by medical practi-
tioners with experience in sleep medicine who are aware of
all options, and who are preferably a part of a specialized
sleep disorders center.
An important issue, not addressed in this review, is the
underuse of oral appliances currently. This is due in part to
the lack of qualified dentists working in this area and in part
to reimbursement policies. At present, the majority of
government-sponsored and private health care providers
will cover (fully or partially) the cost of CPAP, whereas
very few, if any, health care plans will cover the cost of oral
appliances. Considering that this treatment approach is the
only non-invasive alternative to CPAP, it is important to
continue to lobby health care providers to enable this
treatment for qualified patients.
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